» Articles » PMID: 30285887

Assessment of Left Ventricular Systolic and Diastolic Abnormalities in Patients with Hypertrophic Cardiomyopathy Using Real-time Three-dimensional Echocardiography and Two-dimensional Speckle Tracking Imaging

Overview
Publisher Biomed Central
Date 2018 Oct 5
PMID 30285887
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conventional echocardiography is not sensitive enough to assess left ventricular (LV) dysfunction in hypertrophic cardiomyopathy (HCM) patients. This research attempts to find a new ultrasonic technology to better assess LV diastolic function, systolic function, and myocardial longitudinal and circumferential systolic strain of segments with different thicknesses in HCM patients.

Methods: This study included 50 patients with HCM and 40 healthy subjects as controls. The peak early and late mitral annulus diastolic velocities at six loci (E' and A', respectively) and the E'/A' ratio were measured using real-time tri-plane echocardiography and quantitative tissue velocity imaging (RT-3PE-QTVI). The mean value of E' at six loci (E') was obtained for the calculation of E/E' ratio. The LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), LV stroke volume (LVSV), and LV ejection fraction (LVEF) were measured using real-time three-dimensional echocardiography (RT-3DE). LV myocardial longitudinal peak systolic strain (LPSS) and circumferential peak systolic strain (CPSS) in the apical-middle-basal segments (LPSS, LPSS, LPSS; CPSS, CPSS, and CPSS, respectively) were obtained using a software for two-dimensional speckle tracking imaging (2D-STI). According to the different segmental thicknesses (STs) in each HCM patient, the values (LPSS and CPSS) of all the myocardial segments were categorized into three groups and the respective averages were computed.

Results: The E', A', and, E'/A' ratio in HCM patients were lower than those in the controls (all p < 0.001), while the E/E' ratio in HCM patients was higher than that in the controls (p < 0.001). The LVEDV, LVSV, and LVEF were significantly lower in HCM patients than in controls (all p < 0.001). In HCM patients, the LPSS, LPSS, LPSS, CPSS, CPSS and CPSS and the LPSS and CPSS of LV segments with different thicknesses were all significantly reduced (all p < 0.001).

Conclusions: In HCM patients, myocardial dysfunction was widespread not only in the obviously hypertrophic segments but also in the non-hypertrophic segments; the LV systolic and diastolic functions were damaged, even with a normal LVEF. LV diastolic dysfunction, systolic dysfunction, and myocardial deformation impairment in HCM patients can be sensitively revealed by RT-3PE-QTVI, RT-3DE, and 2D-STI.

Citing Articles

Aortic annular plane systolic excursion in cats with hypertrophic cardiomyopathy.

Dutton L, Spalla I, Seo J, Silva J, Novo Matos J J Vet Intern Med. 2023; 38(1):61-70.

PMID: 38038190 PMC: 10800187. DOI: 10.1111/jvim.16962.


Evaluation of global and regional myocardial work in hypertrophic cardiomyopathy patients by left ventricular pressure-strain loop.

Xiao C, Zhao X, Sun L, Zhang F BMC Cardiovasc Disord. 2023; 23(1):479.

PMID: 37759197 PMC: 10538241. DOI: 10.1186/s12872-023-03519-x.


Dynamic evolution of left ventricular strain and microvascular perfusion assessed by speckle tracking echocardiography and myocardial contrast echocardiography in diabetic rats: Effect of dapagliflozin.

Liu J, Wang Y, Zhang J, Li X, Tan L, Huang H Front Cardiovasc Med. 2023; 10:1109946.

PMID: 36910521 PMC: 9996187. DOI: 10.3389/fcvm.2023.1109946.


Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study.

Raman B, Smillie R, Mahmod M, Chan K, Ariga R, Nikolaidou C J Cardiovasc Magn Reson. 2021; 23(1):109.

PMID: 34635131 PMC: 8504076. DOI: 10.1186/s12968-021-00793-6.


Comprehensive Echocardiography of Left Atrium and Left Ventricle Using Modern Techniques Helps in Better Revealing Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy.

Wabich E, Zienciuk-Krajka A, Nowak R, Raczak A, Danilowicz-Szymanowicz L Diagnostics (Basel). 2021; 11(7).

PMID: 34359371 PMC: 8304227. DOI: 10.3390/diagnostics11071288.


References
1.
Urbano-Moral J, Rowin E, Maron M, Crean A, Pandian N . Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2013; 7(1):11-9. DOI: 10.1161/CIRCIMAGING.113.000842. View

2.
Villa A, Sammut E, Zarinabad N, Carr-White G, Lee J, Bettencourt N . Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement. J Cardiovasc Magn Reson. 2016; 18:4. PMC: 4714488. DOI: 10.1186/s12968-016-0223-8. View

3.
Sciagra R, Calabretta R, Cipollini F, Passeri A, Castello A, Cecchi F . Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a NH gated PET study. Eur J Nucl Med Mol Imaging. 2017; 44(5):866-875. DOI: 10.1007/s00259-016-3603-2. View

4.
Liu L, Tuo S, Zhang J, Zuo L, Liu F, Hao L . Reduction of left ventricular longitudinal global and segmental systolic functions in patients with hypertrophic cardiomyopathy: Study of two-dimensional tissue motion annular displacement. Exp Ther Med. 2014; 7(6):1457-1464. PMC: 4043569. DOI: 10.3892/etm.2014.1617. View

5.
Rust E, Albayya F, Metzger J . Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J Clin Invest. 1999; 103(10):1459-67. PMC: 408456. DOI: 10.1172/JCI6377. View